ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Multicenter Valdiation of Urinary Biomarkers in Kidney Transplantation: Urinary CXCL9 Protein Correlates with Acute Rejection and Deterioration of Kidney Function

    D. Hricik, P. Nickerson, R. Formica, E. Poggio, D. Rush, K. Newell, J. Goebel, I. Gibson, R. Fairchild, M. Riggs, D. Ikle, N. Bridges, P. Heeger

    University Hospitals Case Medical Center, Cleveland, OH; University of Manitoba, Winnipeg, MB, Canada; Yale University, Hew Haven, CT; Cleveland Clinic, Cleveland, OH; Emory University Hospital, Atlanta, GA; Cincinnati Children's Hospital, Cincinnati, OH; Rho, Chapel Hill, NC; NIAID, NIH, Bethesda, MD; Mt. Sinai School of Medicine, New York, NY; the CTOT-01 Consortium

    Noninvasive biomarkers to diagnose and/or predict outcomes in kidney transplant recipients are needed to assess post-transplant risk and ultimately to guide management of immunosuppression. Results…
  • 2013 American Transplant Congress

    Peri-Transplant Absolute Lymphocyte Count Is a Reliable Predictive Factor for Advanced Recurrence of Hepatitis C Following Liver Transplantation

    S. Nagai, A. Yoshida, K. Khono, D. Altshuler, M. Nakamura, M. Kazimi, B. Kimberly, M. Abouljoud, D. Moonka

    Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI; Gastroenterology, Henry Ford Hospital, Detroit, MI

    Aim: Lymphocytes play an active role in immunity against HCV. The aim of this study was to investigate the impact of peri-transplant absolute lymphocyte counts…
  • 2013 American Transplant Congress

    Long-Range, CIS-Regulatory Architecture of the IL-2 and IL-21 Multi-Locus Region

    P. Mehra, A. Wells

    Pathology, Perelman School of Medicine at the University of Pennsylvania and The Children's Hospital of Philadelphia, Philadelphia, PA

    IL-2 is a crucial cytokine with roles in both immunity and tolerance, and IL-21 mediates inflammation by promoting B cell and CTL differentiation. These cytokines…
  • 2013 American Transplant Congress

    Antibodies to K-α1 Tubulin and IL 17 Induces Periostin Dependent Pro-Fibrotic Signaling Cascades: A Novel Biomarker Involved in the Pathogenesis of Chronic Lung Allograft Rejection

    V. Tiriveedhi, N. Sarma, R. Hachem, E. Trulock, G. Patterson, T. Mohanakumar

    Surgery, Medicine, Pathology & Immunology, Washington University School of Medicine, St. Louis, MO

    Background: Antibodies (Abs) to K-Α1-tubulin (KΑ1T), an epithelial gap junction cytoskeletal protein, and Interleukin (IL)-17, have been implicated in the pathogenesis of bronchiolitis obliterans syndrome…
  • 2013 American Transplant Congress

    Impact of Donor Age on Three-Year Outcomes in Recipients of Extended Criteria Kidneys Treated with Belatacept vs Cyclosporine in BENEFIT-EXT Trial

    K. Budde, J. Morales, G. Blancho, F. Muehlbacher, F. Lehner, K. Rice, L. Pupim, S. Aigner, F. Vincenti

    Charité Univ Berlin, Germany; Hosp 12 de Octubre Madrid, Spain; Univ Hosp Nantes, France; Med Univ Vienna, Austria; Med Hochschule Hannover, Germany; Baylor Univ Med Ctr, TX; BMS, NJ; BMS, France; UCSF, CA

    Introduction: Belatacept (bela) was associated with improved renal function & similar pt/graft survival & AR rates vs CsA through 3 yrs follow-up in BENEFIT-EXT, the…
  • 2013 American Transplant Congress

    Outcomes at Five Years in Black/African-American Kidney Transplant Recipients from the Long-Term Extension of the Belatacept BENEFIT and BENEFIT-EXT Studies

    S. Florman, K. Rice, L. Chan, R. Zhang, M. Abouljoud, S. Steinberg, T. Pearson, L. Pupim, F. Vincenti

    Mt Sinai Med Ctr, NY; Baylor Univ Med Ctr, TX; Univ of Colorado, CO; Tulane Univ, LA; Henry Ford Hosp, MI; Balboa Inst of Transpl, CA; Emory Univ, GA; BMS, NJ; UCSF Kidney Transpl Svc, CA

    Introduction: Previously reported long-term results of BENEFIT & BENEFIT-EXT demonstrated a consistent safety profile & sustained improvement in renal function vs CsA over time. Here…
  • 2013 American Transplant Congress

    Role of Foxp3 for Augmented Homeostatic Proliferation of Treg, The

    Y. Lin, D. Rothstein

    Thomas E. Starzl Transplantation Institute, Pittsburgh, PA

    CD4+Foxp3+ Tregs play a critical role in transplant tolerance. Foxp3 does not initiate thymic differentiation of natural Treg (nTreg), but is essential for later differentiation…
  • 2013 American Transplant Congress

    Circulating MicroRNAs Correlate with Diabetic Nephropathy and Systemic Microvascular Damage and Normalize after Simultaneous Pancreas-Kidney Transplantation

    R. Bijkerk, M. Khairoun, J. Duijs, K. ter Horst, A. de Vries, E. de Koning, J. de Fijter, T. Rabelink, A. van Zonneveld, M. Reinders

    Department of Nephrology, Leiden University Medical Center, Leiden, Netherlands; Einthoven Laboratory for Experimental Vascular Research, Leiden University Medical Center, Leiden, Netherlands

    Aim: Simultaneous pancreas-kidney transplantation (SPK) is an advanced treatment option for patients with type I diabetes with extensive microvascular disease and nephropathy (DN). Circulating microRNAs…
  • 2013 American Transplant Congress

    Irradiation and T Cell Depletion Augment Bone Marrow-Derived Chimerism at the Cost of Morbidity and Mortality in a Non-Human Primate Model of Vascularized Composite Allotransplantation

    P. Brazio, J. Ha, R. Munivenkatappa, R. Mohan, E. Rodriguez, S. Bartlett, R. Barth

    Department of Surgery, U. Maryland, Baltimore, MD; Division of Transplantation, U. Maryland, Baltimore, MD; Division of Plastic Surgery, R Adams Cowley Shock Trauma Center, U. Maryland, Baltimore, MD

    PurposeWe have shown that vascularized bone marrow (VBM) prolongs vascularized composite allograft survival in nonhuman primates (NHP). To explore the potential for chimerism and tolerance,…
  • 2013 American Transplant Congress

    Liver Transplant for NASH: We Need To Spare the Nephron!

    C. Jordan, N. Pilch, D. Taber, H. Meadows, J. Fleming, A. Mardis, K. Morbitzer, C. Makowski, J. McGillicuddy, C. Bratton, A. Lin, P. Baliga, K. Chavin

    Pharmacy, MUSC, Charleston, SC; Transplant, MUSC, Charleston, SC

    Background: The aim of this study was to evaluate outcomes of patients transplanted for NASH cirrhosis compared to those without NASH.Methods: Single center retrospective longitudinal…
  • « Previous Page
  • 1
  • …
  • 150
  • 151
  • 152
  • 153
  • 154
  • …
  • 178
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences